338 related articles for article (PubMed ID: 22664975)
41. 4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process.
De Luca L; Gitto R; Christ F; Ferro S; De Grazia S; Morreale F; Debyser Z; Chimirri A
Antiviral Res; 2011 Oct; 92(1):102-7. PubMed ID: 21767569
[TBL] [Abstract][Full Text] [Related]
42. Wikstroelide M potently inhibits HIV replication by targeting reverse transcriptase and integrase nuclear translocation.
Zhang X; Huang SZ; Gu WG; Yang LM; Chen H; Zheng CB; Zhao YX; Wan DC; Zheng YT
Chin J Nat Med; 2014 Mar; 12(3):186-93. PubMed ID: 24702804
[TBL] [Abstract][Full Text] [Related]
43. Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation.
Esposito F; Tintori C; Martini R; Christ F; Debyser Z; Ferrarese R; Cabiddu G; Corona A; Ceresola ER; Calcaterra A; Iovine V; Botta B; Clementi M; Canducci F; Botta M; Tramontano E
Chembiochem; 2015 Nov; 16(17):2507-12. PubMed ID: 26360521
[TBL] [Abstract][Full Text] [Related]
44. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75.
De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A
ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598
[TBL] [Abstract][Full Text] [Related]
45. Rational design of LEDGINs as first allosteric integrase inhibitors for the treatment of HIV infection.
Desimmie BA; Demeulemeester J; Christ F; Debyser Z
Drug Discov Today Technol; 2013 Dec; 10(4):e517-22. PubMed ID: 24451643
[TBL] [Abstract][Full Text] [Related]
46. TALEN knockout of the PSIP1 gene in human cells: analyses of HIV-1 replication and allosteric integrase inhibitor mechanism.
Fadel HJ; Morrison JH; Saenz DT; Fuchs JR; Kvaratskhelia M; Ekker SC; Poeschla EM
J Virol; 2014 Sep; 88(17):9704-17. PubMed ID: 24942577
[TBL] [Abstract][Full Text] [Related]
47. Antiviral Activity and Resistance Profile of the Novel HIV-1 Non-Catalytic Site Integrase Inhibitor JTP-0157602.
Ohata Y; Tomonaga M; Watanabe Y; Tomura K; Kimura K; Akaki T; Adachi K; Kodama EN; Matsuzaki Y; Hayashi H
J Virol; 2022 Mar; 96(6):e0184321. PubMed ID: 35045265
[TBL] [Abstract][Full Text] [Related]
48. A highly potent and safe pyrrolopyridine-based allosteric HIV-1 integrase inhibitor targeting host LEDGF/p75-integrase interaction site.
Maehigashi T; Ahn S; Kim UI; Lindenberger J; Oo A; Koneru PC; Mahboubi B; Engelman AN; Kvaratskhelia M; Kim K; Kim B
PLoS Pathog; 2021 Jul; 17(7):e1009671. PubMed ID: 34293041
[TBL] [Abstract][Full Text] [Related]
49. Identification of the LEDGF/p75 binding site in HIV-1 integrase.
Busschots K; Voet A; De Maeyer M; Rain JC; Emiliani S; Benarous R; Desender L; Debyser Z; Christ F
J Mol Biol; 2007 Feb; 365(5):1480-92. PubMed ID: 17137594
[TBL] [Abstract][Full Text] [Related]
50. Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein.
Hayouka Z; Hurevich M; Levin A; Benyamini H; Iosub A; Maes M; Shalev DE; Loyter A; Gilon C; Friedler A
Bioorg Med Chem; 2010 Dec; 18(23):8388-95. PubMed ID: 20974536
[TBL] [Abstract][Full Text] [Related]
51. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.
Hombrouck A; De Rijck J; Hendrix J; Vandekerckhove L; Voet A; De Maeyer M; Witvrouw M; Engelborghs Y; Christ F; Gijsbers R; Debyser Z
PLoS Pathog; 2007 Mar; 3(3):e47. PubMed ID: 17397262
[TBL] [Abstract][Full Text] [Related]
52. Insight into the fundamental interactions between LEDGF binding site inhibitors and integrase combining docking and molecular dynamics simulations.
De Luca L; Morreale F; Chimirri A
J Chem Inf Model; 2012 Dec; 52(12):3245-54. PubMed ID: 23194297
[TBL] [Abstract][Full Text] [Related]
53. 5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors.
Peese KM; Allard CW; Connolly T; Johnson BL; Li C; Patel M; Sorensen ME; Walker MA; Meanwell NA; McAuliffe B; Minassian B; Krystal M; Parker DD; Lewis HA; Kish K; Zhang P; Nolte RT; Simmermacher J; Jenkins S; Cianci C; Naidu BN
J Med Chem; 2019 Feb; 62(3):1348-1361. PubMed ID: 30609350
[TBL] [Abstract][Full Text] [Related]
54. Structure-based virtual screening toward the discovery of novel inhibitors for impeding the protein-protein interaction between HIV-1 integrase and human lens epithelium-derived growth factor (LEDGF/p75).
Panwar U; Singh SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3199-3217. PubMed ID: 28948865
[TBL] [Abstract][Full Text] [Related]
55. Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups.
Fan X; Zhang FH; Al-Safi RI; Zeng LF; Shabaik Y; Debnath B; Sanchez TW; Odde S; Neamati N; Long YQ
Bioorg Med Chem; 2011 Aug; 19(16):4935-52. PubMed ID: 21778063
[TBL] [Abstract][Full Text] [Related]
56. HIV-1 integrase modulates the interaction of the HIV-1 cellular cofactor LEDGF/p75 with chromatin.
Astiazaran P; Bueno MT; Morales E; Kugelman JR; Garcia-Rivera JA; Llano M
Retrovirology; 2011 Apr; 8():27. PubMed ID: 21510906
[TBL] [Abstract][Full Text] [Related]
57. Effective prediction model and determination of binding residues influential for inhibitors targeting HIV-1 integrase-LEDGF/p75 interface by employing solvent accessible surface area energy as key determinant.
Thangsunan P; Wongsaipun S; Kittiwachana S; Suree N
J Biomol Struct Dyn; 2020 Feb; 38(2):460-473. PubMed ID: 30744499
[TBL] [Abstract][Full Text] [Related]
58. In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer.
Voet AR; Maeyer MD; Debyser Z; Christ F
Future Med Chem; 2009 Oct; 1(7):1259-74. PubMed ID: 21426102
[TBL] [Abstract][Full Text] [Related]
59. Single-Cell Imaging Shows That the Transcriptional State of the HIV-1 Provirus and Its Reactivation Potential Depend on the Integration Site.
Janssens J; De Wit F; Parveen N; Debyser Z
mBio; 2022 Aug; 13(4):e0000722. PubMed ID: 35708287
[TBL] [Abstract][Full Text] [Related]
60. [LEDGF/p75: a novel target for anti-HIV therapy and advances in the study of its related inhibitors].
Chen WM; Liu XY
Yao Xue Xue Bao; 2009 Sep; 44(9):953-60. PubMed ID: 20055168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
